| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2017/3713025 |
| P8608 | Fatcat ID | release_s4aovkko3fgdfm7jjrrulqowha |
| P932 | PMC publication ID | 5684519 |
| P698 | PubMed publication ID | 29226133 |
| P50 | author | Adrianna Mostowska | Q73480851 |
| Alicja E Grzegorzewska | Q88357819 | ||
| Monika K Świderska | Q88357822 | ||
| Paweł Jagodziński | Q60220360 | ||
| P2860 | cites work | IL-28, IL-29 and their class II cytokine receptor IL-28R | Q24323830 |
| IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex | Q24336912 | ||
| Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
| IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques | Q24630281 | ||
| Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity | Q24642027 | ||
| Prophylactic vaccinations in chronic kidney disease: Current status | Q26827388 | ||
| Lambda interferon inhibits hepatitis B and C virus replication | Q27469456 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults | Q28278176 | ||
| Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation | Q28591402 | ||
| Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 | ||
| Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Q30984322 | ||
| Clinical relevance of cytokine production in hemodialysis. | Q33998562 | ||
| Adipokines as uremic toxins | Q34112301 | ||
| IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population | Q34287407 | ||
| Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis | Q34604379 | ||
| Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses | Q34960553 | ||
| Interferon lambdas: the next cytokine storm | Q35154826 | ||
| Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection | Q35165398 | ||
| Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration | Q35596521 | ||
| Effect of uremia on structure and function of immune system | Q35635884 | ||
| Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection | Q35865362 | ||
| Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing | Q36698750 | ||
| Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. | Q37196855 | ||
| IDO: a double-edged sword for T(H)1/T(H)2 regulation | Q37281950 | ||
| Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver | Q37684887 | ||
| Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines | Q38242238 | ||
| Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression. | Q38792478 | ||
| Analysis of small peptide in uremic serum by high-performance liquid chromatography | Q70340364 | ||
| Acute hepatitis C among renal failure patients on chronic haemodialysis | Q77299024 | ||
| Immunization with HBsAg-Fc fusion protein induces a predominant production of Th1 cytokines and reduces HBsAg level in transgenic mice | Q84957532 | ||
| Hepatitis C in Poland in 2014 | Q39168223 | ||
| Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics | Q40211546 | ||
| Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes | Q40226559 | ||
| Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients | Q40551804 | ||
| Antibodies to hepatitis B virus surface antigen and survival of hemodialysis patients - a prospective study | Q40679493 | ||
| Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. | Q40956888 | ||
| The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus | Q41564761 | ||
| Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. | Q41602462 | ||
| High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients | Q42264676 | ||
| IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. | Q42979018 | ||
| Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. | Q42999224 | ||
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Q43047523 | ||
| The long-term outcome of hepatitis B infection in hemodialysis patients | Q44124931 | ||
| Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure | Q44669924 | ||
| Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management | Q45274404 | ||
| Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population | Q45365068 | ||
| Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients. | Q54705100 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P304 | page(s) | 3713025 | |
| P577 | publication date | 2017-10-31 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients | |
| P478 | volume | 2017 |
Search more.